A1 Refereed original research article in a scientific journal
Prenatally androgenized PCOS mice have ovary-independent uterine dysfunction and placental inflammation aggravated by high-fat diet
Authors: Luyckx, Lena; Myllykangas, Milena; Saarela, Ulla; Virtanen, Nikke; Hurskainen, Elisa; Savolainen, Audrey; Ollikainen, Nadja; Norlén, Anna-Karin; Ohlsson, Claes; Poutanen, Matti; Velde, Greetje Vande; Arffman, Riikka K.; Prunskaite-Hyyryläinen, Renata; Vriens, Joris; Piltonen, Terhi T.
Publisher: AMER ASSOC ADVANCEMENT SCIENCE
Publishing place: WASHINGTON
Publication year: 2025
Journal: Science Advances
Journal name in source: SCIENCE ADVANCES
Journal acronym: SCI ADV
Article number: eadu3699
Volume: 11
Issue: 19
Number of pages: 15
ISSN: 2375-2548
eISSN: 2375-2548
DOI: https://doi.org/10.1126/sciadv.adu3699
Web address : https://doi.org/10.1126/sciadv.adu3699
Self-archived copy’s web address: https://research.utu.fi/converis/portal/detail/Publication/498669516
Polycystic ovary syndrome (PCOS) is a common hyperandrogenic and metabolic condition in women. The syndrome is linked to subfertility and pregnancy complications, yet the independent effects of exposure to hyperandrogenism and obesity on endometrial function remain unclear. Here, PCOS-like mice were generated using prenatal androgenization (PNA) with dihydrotestosterone, followed by a prepubertal high-fat (HF) or standard diet. In ovariectomized mice, PNA impaired uterine closure during the implantation window, disrupted decidualization, and altered extracellular matrix- and inflammation-related gene expression. The effects were aggravated by the HF diet. In naturally mated, ovary-intact mice, PNA and HF diet affected decidual and placental gene expression, suggestive of placental dysfunction and inflammation, and induced fetal growth restriction. This study underlines the role of the uterus in adverse pregnancy outcomes in PCOS and identifies possible underlying mechanisms for future studies. Prepregnancy interventions targeting metabolic health and hyperandrogenism should be the next steps to optimize PCOS pregnancy outcomes.
Downloadable publication This is an electronic reprint of the original article. |
Funding information in the publication:
This work was supported by the Horizon 2020 Marie-Curie MATER Innovative Training Network [813707 (T.T.P.)], the Oulu Scholarship Foundation Grant (L.L.), the Jusélius Foundation (T.T.P.), the Novo Nordisk Foundation [NNF21OC0070372 (T.T.P.)], the Research Council of Finland [315921, 321763, and 336449 (R.K.A. and T.T.P.)], and Fonds Wetenschappelijk Onderzoek [I006524N and G0A6719N (G.V.V. and J.V.)].